Replies to post #109407 on Avid Bioservices Inc (CDMO)

[freethemice]

I don't have any doubt either. The increase in MOS of 1.8 months (27%) wasn't much, but it
was highly significant. It was one of the largest trials ever done in pancreatic cancer. That is
what it takes to get significance for such a small increase.